Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

NS, CV and renal pharmacology > NS, CV and renal pharmacology > Flashcards

NS, CV and renal pharmacology Flashcards

1
Q

What is the treatment for second and third degree heart block?

A

Emergency treatment required - Atropine (IV) or Isoprenaline (IV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Class I Anti-arrhythmic drugs

A

Sodium channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Class II anti-arrhythmic drugs

A

Beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Class III anti-arrhythmic drugs

A

K+ channel blockers/Prolong A.P duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Class IV anti-arrhrhymic drugs

A

Calcium channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the differences between Class Ia,b and C anti-arrhythmic drugs?

A

Differences due to recovery/unbinding of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the main affect of Class I anti-arrhrhymic drugs?

A

Block Na+ channels to decrease phase 0 - depolarisaiob

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dysopyramide

A

Sodium channel blocker (Class 1A anti-arrhythmic drug) used to treat ventricular arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lidocaine (IV)

A

Sodium channel blocker (Class 1b anti-arrhrhymic drug) used in treatment prevention of ventricular tachycardia and fibrillation during and immediately after myocardial infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Flecainide

A

Sodium channel blocker (Class 1c anti-arrhrhymic drug) used to prevent paroxysmal atrial fibrillation and recurrent tachyarrythmias associated with abnormal conduction pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Amiodarone, sotalol, Bretylium

A

K+ channel blockers, prolong A.P depolarisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Amidarone used to treat?

A

Tachycardia associated with WPW syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Sotalol used to treat?

A

used in paraxysmal supraventricular dsyrthmias and suppresses ventricular ectopic beats, and short runs of ventricular tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

outline the mechanism of CCB’s

A

act on L-type channels, shorten the plateau of the AP and reduce the force of contraction. Reduced Ca2+ entry reduces after depolarisation and thus suppresses premature ectopic beats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Veramapil

A

CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diltiazem

A

CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

outline the side effects of CCBs?

A

bradycardia, negative inotropic effect, constipation (verapamil), hypotension (diltiazem)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Loop diuretics, site of action

A

Act on thick ascending limb (TAL) of loop of Henle to inhibt Na+/K+/Cl-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Furosemide, Butetamide

A

Loop diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Thiazides site of action

A

Distal tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why might thiazides be preferred over loop diuretics?

A

Thiazides are less powerful than loop diuretics so preferred in treating uncomplicated hypertension. In contrast to loop diuretics thiazides reduce Ca2+ excretion and so is favourable in elderly patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Thiazides mechanism of action

A

Bind to the Cl- site of distal tubular Na+/Cl- cotransport system inhibiting its action causing natriuresis with loss of Na+ and Cl-, results in reduced blood volume.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Clinical uses of thiazide diuretics

A

Hypertension, mild heart failure (loop diuretics preferred), severe resistant oedema, nephrogenic diabetes insipidus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Adverse effects of loop diuretics and thiazides

A

hypotension, gout, hypokalemia (caues dysrhythmias, increased digoxin toxicity and hyperglycaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Potassium sparing diuretics- site of action

A

Act exclusively on distal parts of nephron: collecting tubule and collecting duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Aldosterone antagonist - mechanism of action

A

Competitive inhibtion of intracellular aldosterone receptors, decreases the numbre of luminal Na+ channles and decreases number of basolateral Na+-K+-ATPases. This inhibits Na+ retention and K+ secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Spironolactone

A

Potassium sparing diuretic - aldosterone antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Na+ channel blockers - mechanism of action

A

Inhibit Na+ re-absorption by blocking lumenal sodium channels and decreasing K+ excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Triameterene, Amiloride

A

Potassium sparing diuretic - Na+ channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Clinical uses of potassium sparing drugs

A

used with K+ losing diuretics, heart failure, primary aldosteronism (conns syndrome), resistant essential hypertension, secondary hyperaldosteronism caused by hepatic cirrhosis complicated by ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Osmoitic diuretics - site of action

A

Main effect is exerted on parts of the nephron that are FREELY permeable to water: proximal tubule, descending limb of the loop and collecting tubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Osmotic diuretics - mechanism of action

A

Increase filtrate osmolairty, passive water reabsoprtion is reduced by the presence of non reabsorbable solute within the tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Clinical use of Osmotic diuretics

A

Used in emergency treatment of acutely raised intraocular or intracranial pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Clinical uses of carbonic anhydrase inhibitors

A

Glaucoma, altitude sickness, little use as a diuretic drug due to rapid tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What is nephrotic syndrome?

A

Increased permeability of the glomerular basement membrane to proteins leading to proteinuria. Increases volume of interstitial fluid leading to tissue swelling and activation of RAAS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Treatment of glomerular nephritis

A

Antihypertensive, loop diuretic, immunosuppresive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Consquences of glomerular nephritis

A

Acute renal failure, chronic renal failure, dialysis or transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Acute Kidney Injury

A

Abrupt reduction in kidney function resulting in failure to maintain fluidm electrolye, and acid-base homeostasis. Decreased urine production and fluid-electrolyte imbalance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Pre-renal causes of AKI

A

Causes that decrease effective blood flow to the kidney e.g. reduced cardiac output - heart failure, MI, bradycardia. Drugs - ACE inhibitors, NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Renal causes of AKI

A

Blockage of renal vasculature = uric acid crystals, cholesterol emboli, vasculitis, endothelial damage (blood clots). Glomerulonenephritis Interstitial nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Post renal causes of AKI

A

Urinary tract obstruction, benign prostatic hypertrophy, cancers/tumours, stones, non-emptying bladder, crystal deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Disopyramide, procainamine, quinidine

A

Class 1a antiarrythmic drugs - sodium channel blockers. Intermediate dissociation rate, leading to moderate decrease in phase 0 and increased QRS and QT interval Used to treat AF (triggered by vagal overreactivity) and VT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

lidocaine, mexiletine

A

Class 1b anti-arrhythmic drugs -sodium channel blockers. Fast dissociation rate, decreased AP duration and QT interval. Used to treat and prevent VT and VF immediatley after Myocardial infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Flecainide, Moncizine, propafenone

A

Class 1c anti-arrhythmic drugs, blocks with slow dissociation rate causing large decrease in phase 0, leading to increased QRS and QT interval. Used to treat AF and recurrentt tachycardias associated with adnormal conduction pathways and WPW syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Class 1a anti-arrhythmic drugs side effects

A

Atropine like (urinary retention, dry mouth, blurred vision, constipation) and Quinide causes syncope (due to triggering torsades de pointes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Class 1b anti-arrhythmic drugs side effects

A

CNS, drowsiness, disorientation and convulsions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Beta blockers mechanism

A

Block cardiac B1 adrenoreceptors to reduce sympathetic drive to the heart, decreasing heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Propranolol

A

Non selective B antagonist, long acting, oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Timolol

A

Non selective B antagonist, used to treat glaucoma (decreases AH formation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Atenolol, bisoprolo, metoprolol

A

B1 Selective antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Pindolol

A

B1 Selective partial agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Nevbivolol

A

B1 selective antagonist and also increases NO (leading to less fatigue, bradycardia,and impotence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Labetalol

A

Mixed alpha/beta adrenergic antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Carvedilol

A

Mixed Alpha1/beta antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Clinical uses of beta blockers

A

Rate control in SVT, rate and rhythm control in AF and flutter, VT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Adverse effects of B blockers

A

Bronchospasm (caution in asthma), negative inotropic effect, bradycardia, fatigue, increased risk of hypoglycaemia (diabetics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Sotalol, amiodarone, bretylium

A

Class 3 anti-arrhythmic drugs-prolong AP duration by prolong phase 3 by blocking K+ channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Amidarone

A

K+ channel blocker. Also a modest Na+ and Ca2+ blocker and alpha adrenergic receptor antagonist and decreases cardiac B1 adrenergic receptor expression. When given orally has slow onset (up to 3 weeks) and a very long plasma half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Amidarone side effects

A

thyroid abnormalities, corneal deposits, pulmonary disorders, skin pigmentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Class 3 anti-arrhythmic drugs clinical uses

A

SVTs, WPW syndrome, ventricular tachycardias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Sotalol

A

Class 3 anti-arrhythmic also a non selective B blocker. Lacks the adverse ADRs seen in amidarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Verapamil, Diltiazen

A

Class IV anti-arrhythmic drugs. Calcium channel blockers to slow down AVN conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Therapeutic uses of Class IV anti-arrhythmic drug

A

paroxsmal SVT, AF (but NOT if due to WPW)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Class IV anti-arrhythmic drug side effects

A

bradycardias, negative inotropic effect, constipation (verapamil), hypotension (more with diltazem)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Ist line treatment for hypertension <55 years

A

ACE inhibitor or angiotensin receptor AT1 blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Captopril, Enalapril

A

ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

ACE inhibitors effects

A

reduce TPR with little effect on HR or cardiac output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

ACE inhibitors adverse effects

A

Dry cough (due to accumulation of bradykinin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Losortan, Candesartan

A

Angiotensin receptor (AT1) blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

?Why mgiht AT1 blockers be preffered over ACE inhibitors

A

NO dry cough - no bradykinin accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Aliskiren

A

Renin inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Renin inhibitors

A

e.g. Aliskiren. reduces plasma renin activity by binding and inhibiting activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Contraindication of RAAS inhibitors

A

In pregnancy (due to fetotoxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Common ADRs of RAAS inhibitors

A

hypotension (with thiazides), hypersemsitvity (head & neck angioedema), hyperkalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

1st line hypertension treatment in African/Carribbean and elderly (>55 years)

A

Calcium channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Nifedipine, Amlodipine

A

CCB, dihydropines, act preferentially on vascular smooth muscle, use in hypertension and angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Phenylalkylamines

A

Verapamil - CCB act on cardiac preferentially

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Benzothiazepines

A

Diltiazem, CCB with an intermediate effect on cardiac and smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

ADRs of Calcium channel blockers

A

Postural hypotension, flushes/tremors (nifedipine), AV block and negative ionotropic effects (verapamil, diltiazem)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Treatment for hypertension when ACEi/CCBs do not work?

A

Also give patient diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Treatment in resistant hypertension

A

B Blockers and alpha antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Statins, fibrates, bile-acid binding resins

A

Lipid lowering drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Statins mechanism

A

inhibits HMG-CoA reductase (key enzyme in cholestrol production)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Simvastatin, Atorvastatin, Pravastatin

A

Statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Clinical uses of Statins

A

Primary and secondary prevention of CHD, (in patients with chronic kidney disease, diabetes type 1 and 2) familial hypercholesterolaemias, in children (>10years)

86
Q

Contraindications in statins

A

In pregnancy

87
Q

Statins ADRs

A

Muscle. (more serious: myopathies, hepatotoxicity)

88
Q

Fibrates mechanism and effects

A

activator of peroxisomal proliferator activator receptor (PPARalpha) leads to increasedity, lipoprotein lipase activity and increase HDL synthesis

89
Q

Clinical uses of Fibrates

A

In combination with statins/ in various dyslipidaemias

90
Q

Fenofibrate, gemfribrozil

A

Fibrates (lipid lowering drugs)

91
Q

Colestyramine, cholestipol

A

Bile acid binding resins (lipid lowering drugs)

92
Q

Bile acid binding resins mechanism and effects

A

Enhance plasma cholesterol clearance via enterohepatic circulation. Get decrease in LDL (but no increase in HDL and triglyceride :( )

93
Q

Clinical uses of bile acid binding resins

A

In patients with liver disease/pregnancy (with caution) when statins are not recommended

94
Q

Ezetimibe

A

Lipid lowering drug, decreases cholesterol absoroption

95
Q

Nicotinic acid/Niacin

A

Lipid lowering drug

96
Q

Aspirin

A

COX-1 Inhibitors (antiplatlet agent)

97
Q

Clopidogel mechanism

A

Antagonists of ADP Receptors (antiplatlet drug). Reduced expression of GPIIb/IIIa leads to platlet aggregation

98
Q

Dipyridamole

A

Phosphodisterase inhibitors

99
Q

ABCIXIMAB, Eptifibatide, tirofiban

A

Glycoprotein IIb/IIIa receptor inhibitors

100
Q

Aspirin therapeutic uses

A

Primary prevention of ACS (in stable angina):Low dose Aspirin 75-150mg/day

In unstable angina: higher loading doses 150-300mg

Secondary prevention of MI = in combination with ACEI, statins and B blockers

101
Q

Aspirin Side Effects

A

GI bleeding, Cerebral Haemorrhage

102
Q

Clopidogrel clincial uses

A

Secondary prevention of MI (with aspirin or alone)

103
Q

Anticoagulant mechanism of Heparin

A

Binds reversibly to to antithrombin III (ATIII) and greatly accerlates the rate at which it inactivates coagulation enzymes thrombin and factor Xa

104
Q

Side effects of Heparin

A

Bleeding, immune thrombocytopenia, osteoporosis, hypersensitivity

105
Q

Protamine Sulfate

A

Herpain antagonist (IV admin) used to to stop bleeding caused by heparin

106
Q

Fondapariunux

A

Synthetic pentasaccheride inhibitor of activated factor Xa

107
Q

Fondaparinux clinical uses

A

Acute coronary syndromes (unstable angina, NSTEMI, STEMI), stroke, deep-vein thrombosis, pulmonary embolism, prophylaxis of venous, thromboembolism follwoing orthapedic surgery

108
Q

Enoxaparin

A

Low molecular weight Heparin

109
Q

Hirudin, Bivalirudin

A

Direct thrombin inhibitors

110
Q

Direct thrombin inhibitors therapeutic uses

A

Prevention of stroke and systemic embolism. Prophylaxis of venous thromboembolism (After hip or knee replacement surgery)

111
Q

Rivaroxaban

A

Selective factor Xa inhibitor

112
Q

Warfain

A

Oral anticoagulant. Inhibits Vitamin K reductase

113
Q

Warfain -drug interactions

A

Antibiotics (decreased vitamin K avalibilty) excess alcohol (increases warfain), drugs inhibiting hepatic drug metabolism, NSAIDS (increase internal bleeding) Hypothyroidism (decreases warfain) and Hyperthyroidism (ncrease warfain)

114
Q

Warfain: side effects and contraindication

A

Bleeding.

Teratogenic (avoid in 1st trimester in pregnancy)

115
Q

Clinical uses of anticoagulants

A

treatment of unstable angina (NSTEMI), Prophylaxis of venous thromboembolism,

116
Q

Alteplsae

A

fibrinolytic agent - recombinant tPA. Prevents conversion of plasminogen to plasmin

117
Q

Reteplase

A

Fibrinolytic agents- recombinant tPA prevents conversion of plasminogen to plasmin

118
Q

Streptokinase

A

fibronlytic agent

119
Q

Urokinase

A

fibrinolytic agents

120
Q

Tranexamic acid

A

anti-thrombolytic

121
Q

First line treatment of heart failure

A

ACE inhibitor +B-blocker + Diuretic

122
Q

Digoxin, Oubain

A

Cardiac glycosides

123
Q

Milrinone, Enoximone

A

Phoshodiesterase type 3-inhibitors cardiac selective

124
Q

Minoxidil, Diazoxide, Nicorandil

A

Potassium (ATP-sensitive) channel activators (openers)

125
Q

Uses and effects of phoshodiesterase inhibitors in CHF

A

Use: short term treatment in acute decompensation of CHF

Effects: increased CO, reduced right atrial pressure, reduced TPR, overall has little affect of HR and BP

126
Q

Phosphodiesterase inhibitors side effects

A

Nausea, vomiting, liver abnormalities, thrombocytopenia, lethal arrthymias (with prolonged use)

127
Q

Glyceral trinitrate, isosorbide dinitrate, isosorbide mononitrate, sodium nitroprusside

A

Nitrates, and nitric oxide releasing drugs

128
Q

Ivabradine

A

I (funny) current inhibitors (SA node)

129
Q

Ranolazine

A

blocker of persistent cardiac sodium channels

130
Q

Moxonidine

A

Imidazoline I1 receptor agonists

131
Q

Levosimendan

A

Calcium sensitising positive inotropes

132
Q

Loop diuretics. Site of action

A

Thick ascending limb of the loop of henle

133
Q

Loop diuretics. Mechanism

A

Inhbition of the luminal Na+ /K+/2Cl- cotransporter

134
Q

Furosemide, Bumetanide

A

Loop diuretics

135
Q

loop diuretics - therapeutic uses

A

For treatment of salt and water overload in: acute pulmonary oedema, CHF, renal failure, nephrotic syndrome.

Liver cirrhosis with ascites

Hypertension complicated by renal impairment

136
Q

Thiazides site of action

A

early distal tubule

137
Q

Thiazides mechanism

A

Inhibition of Na+/Cl- transporter

138
Q

Bendroflumethiazide, Chlorothiazide

139
Q

Chlortalidone, Indapamide, Metolazone

A

Thiazide-like drugs

140
Q

Thiazides therapeutic uses

A

hypertension, in mild heart failure, severe resistant odema, prevention of kidney stone formation in idiopathic hypercalcicuria, nephrogenic diabetes insipidus

141
Q

Adverse effects of loop diuretics and thiazides

A

Hypotension, Gout, Hypokalaemia (Dysrhythmias, increased digoxin toxicity, hyperglycaemia)

142
Q

Spironalactone, Epleronone

A

Aldoesterone antagonists (Potassium sparing diuretic)

143
Q

Amiloride, Triamterene

A

Na+ channel epithelial blockers

144
Q

Potassium sparing diuretics therapeutic uses

A

To prevent hypokalalemia, heart failure, resistant essential hypertension, aldosteronisms

145
Q

Adverse effects of potassium sparing diuretics

A

Main= hyperkalaemia (more common in patients with renal diseases)

146
Q

Mannitol

A

Osmotic diuretic

147
Q

Mechanism of osmotic diuretics

A

Increase filtrate osmolarity. decreasing passive water reabsorption. Act of parts of the nephron freely permeable to water: Proximal tubule, descending limb of loop of henle, collecting tubule (in the presence of ADH)

148
Q

Osmotic diuretics therapeutic uses

A

In acute renal failure.

Non renal uses: in emergency treatment of raised intracranial and intraocular pressure (glaucoma)

149
Q

Acetazolamide

A

Carbonic anhydrase inhibitors

150
Q

Carbonic anhydrase inhibitors clinical uses

A

Glaucoma, alitude thickness - little use as a diuretic drug due to rapid tolerance

152
Q

Phenylephrine - site of action

A

alpha 1 selective agonist

153
Q

Phenylephrine and Methoxamine uses

A

Selective Alpha 1 agonists cause smooth muscle constriction, used as nasal decongestants

154
Q

Methoxamine

A

Selective alpha 1 agonist

155
Q

Clonidine - site of action and effects

A

Selective alpha 2 agonist prevents NA release and hence reduces BP used as an antihypertensive

156
Q

Dobutamine - site of action

A

B1 agonist

157
Q

Dobutamine effects and uses

A

Dobutamine is an B1 agonist which increases cardiac contractility and so is used to treat cardiogenic shock

158
Q

Adrenaline - therapeutic uses

A

Cardiac arrest and anaphylatic shock

159
Q

Terbutaline -site of action

A

B2 agonist

160
Q

Carbidopa

A

Inhibits NA synthesis by inhibiting DOPA decarboxylase. Used to treat parkisons disease alongside Levodpa

161
Q

alpha-methyl-p-tyrosine

A

Inhibits tyrosine hyroxylase, inhibiting synthesis of NA - prossible us in phaechromocytoma

162
Q

Isoprenaline

A

NON SELECTIVE Beta agonists

163
Q

Oxymetazoline

A

NON SELECTIVE alpha agonist

164
Q

Doxazocin, Prazosin - site of action

A

Selective alpha 1 agonists

165
Q

Effects of Prazosin

A

Alpha 1 antagonist causing vasodilation and fall in aterial pressure (smooth muscle relaxation of bladder)

166
Q

Yohimbine - site of action

A

Selective alpha 2 antagonist

167
Q

Amphetamine, Tyramine

A

Indirectly acting sympathimimetic. Substrate for NET - rapidly displaces NA and increases NA in the synapse.

168
Q

Cocaine, impramine

A

Inhibits NET -and therefore NA uptake, increasing NA in synapse

169
Q

Guanethidine

A

Substrate for NET and VMAT. Displaces NA slowly (high doses will destory neurones)

170
Q

Reserpine

A

Inhibits VMAT and therefore vesicular NA uptake. Free NA is metabolised by MAO

171
Q

Side effects of Reserpine

A

Depression and parkinsonism

172
Q

NA is metabolised by what two enzymes

A

Monoamine Oxidase (MAO) and Catechol-O-methyl transferase

173
Q

Alpha-methyldopa

A

False NA precursor. Metabolised to methyl-NA acts as a alpha 2 agonist (this inhibits release of NA), used to treat pregnancy induced hypertension.

175
Q

Carbachol

A

Muscarinic receptor agonists

176
Q

Bethanecol

A

Muscarinic agonist - use to assist bladder empyting or to stimulate GI

177
Q

Pilocarpine

A

Muscarinic receptor agonist - selectivity for constrictor pupillae, sweat, salivary, lacrimal. (minimal activity on smooth muscle and heart) Used to treat glaucoma. Stable compound actions last for one day.

178
Q

Oxotremorine

A

Muscarinic agonist

179
Q

Methacholine

A

Muscarinic receptor agonist

180
Q

Atropine

A

NON Selective muscarinic antagonist

181
Q

Clinical uses of Atropine

A

Adjunct anaesthia, treat anticholinsterase poisoning, bradycardia, GI hypermotility

182
Q

Atropine side effects

A

Urinary retention, dry mouth, blurred vision, constipation

183
Q

Scopolamine

A

Non selective muscarinic receptor antagonist.

184
Q

Pirenzipine

A

M1 selective antagonist - treatment for peptic ulcers

185
Q

Ipratropium

A

Non selective muscarinic antagonist

186
Q

What is Ipratripiom used to treat?

A

Irritant induced bronchospasm by inhilation/nebulisers, asthma, bronchitis, COPD

187
Q

Tioptropium

A

Simular to Iproatropium but with improved PK. Binds to all muscarinc receptors - but with so M3 selectivity

188
Q

Oxybutynin

A

M3 selective antagonist

189
Q

Nicotinine

A

Stimulates autonomic ganglia, leads to tachycardia, increased BP and increased secretions

190
Q

Trimetaphan

A

Blocks nicotinic receptors and therefore action of ACH. used for emergency lowering of blood pressure

191
Q

Hexamethonium

A

Blocks channels on autonomic ganglia - doesnt not compete with ACh

192
Q

Hemicholinium

A

Blocks the uptake of choline

193
Q

Botulinum toxin

A

Prevents vesicles fusing and releasing ACh (Botox)

194
Q

Vesamicol

A

Vesamicol acts presynaptically by inhibiting ACh uptake into synaptic vesciles leads to empty vesicles fusing with neuron membranes and reducing ACh release.

195
Q

Tubocurarine

A

non depolarising competitve nACh receptor antagonist

196
Q

Gallamine

A

Non depolarising competitive nACh antagonist - synthetic analogue of tubocuraine

197
Q

Pancuronium

A

non depolarisng competitive nACh antagonist - synthetic analogue of tubocuraine

198
Q

Suxamethonium

A

Nicotinic acetylcholine receptor agonist, depolarizing neuromuscular blocker, resulting in persistent depolarization of the motor end plate. Used to induce short term muscle relaxation and short term paralysis

199
Q

α-Bungarotoxin

A

Bind irreversibly and competitively to the nACh receptors causing paralysis and respiratory failure

200
Q

Triethylcholine

A

Acts presynaptically. It is a drug that mimics choline (false transmitter) and causes failure of cholinergic transmission by interfering with synthesis of acetylcholine in nerve endings.

201
Q

Streptomycin

A

Inhibits Ca2+ entry presynaptically

202
Q

Neomycin

A

Inhibits Ca2+ entry presynaptically

203
Q

ß-Bungarotoxin

A

Acts pre-synaptically to block ACh release

204
Q

Neostigmine

A

Parasympathomimetic that binds and inhibits acetylcholinesterase. Used in people with myasthenia gravis.

205
Q

Edrophonium

A

Anticholinesterase reversible inhibitor

206
Q

Physostigmine (Eserine)

A

Physostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor which effectively increases the concentration of acetylcholine at the sites of cholinergic transmission. Physostigmine is used to treat glaucoma. Because it crosses the blood-brain barrier, it is also used to treat the central nervous system effects of atropine overdose and other anticholinergic drug overdoses

207
Q

Disopropyl fluorophosphate (DFP)

A

Diisopropyl fluorophosphate is a parasympathomimetic drug irreversible anti-cholinesterase and has been used in ophthalmology as a miotic agent in treatment of chronic glaucoma

208
Q

Sarin

A

Inhibitor of anticholinisterase

209
Q

Pralidoxime

A

Dyflos/Sarin antidote

NS, CV and renal pharmacology (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions